Active	Status	Sponsor type	Region	Phase	Filter
2 Active 0 Inactive 2 All	Not yet recruiting Recruiting Enrolling by invitation Active, not recruiting Available No longer recruiting	Industry lead sponsor Industry collaborator Coop Other	US Canada Japan Europe RoW	N/A 1 2 3 4	Highlight changes:- Show only changed items Enrollment:

Advanced Filters

2 Trials

Active Trials   

 

Export

Trial + Data / Events	Status	Ph	N	Region	Interventions	Sponsor	Conditions	Primary compl	Study compl
Wand, Ori
BBT877-IPF-004, NCT05483907: To Evaluate the Efficacy, Safety, and Tolerability of BBT-877 in Patients with IPF Jul 2023 - Dec 2023 : Interim data for the treatment of IPF Initiation of trial in idiopathic pulmonary fibrosis Nov 2022 - Nov 2022: Initiation of trial in idiopathic pulmonary fibrosis	Active, not recruiting	2	129	Europe, US, RoW	BBT-877, Placebo	Bridge Biotherapeutics, Inc.	Idiopathic Pulmonary Fibrosis	01/25	09/25
NCT05119374: Clinical Evaluation of SenseGuard™ to Detect Respiratory Changes, During Home Monitoring of Subjects With High Risk of AECOPD.	Completed	N/A	57	RoW	SenseGuard Investigational Device	NanoVation	Chronic Obstructive Pulmonary Disease (COPD)	02/24	02/24